Skip to main content
. Author manuscript; available in PMC: 2020 Jul 12.
Published in final edited form as: ACS Infect Dis. 2019 Apr 26;5(7):1223–1230. doi: 10.1021/acsinfecdis.9b00067

Table 1.

Activity of Compounds Identified from Initial Screen for Potentiation of Macrolide Antibiotics against AB5075 (MIC fold reductions in parentheses)

Compound MIC (μM) Cone Tested (μM) Erythromydn MIC (μg/mL) Clarithromydn MIC (μg/mL) Azithromycin MIC (μg/mL)
32 32 64
1 100 30 4 (8) 0.25 (128) 8 (4)
2 100 30 4 (8) 0.25 (128) 8 (4)